New Key Statistics Module, Z-Score and F-Score
NAS:RARE Key Ratios
| Market Cap $ M | 3,553.95 |
| Enterprise Value $ M | 3,019.91 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 12.78 |
| Price/Sales | 7.25 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 434.00 |
| EPS (TTM) $ | -8.33 |
| Beneish M-Score | -2.2 |
| 10-y EBITDA Growth Rate % | -14.30 |
| 5-y EBITDA Growth Rate % | -16.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.57 |
| EV-to-EBITDA | -5.85 |
| PEG | -- |
| Shares Outstanding M | 83.13 |
| Net Margin (%) | -139.70 |
| Operating Margin % | -131.08 |
| Pre-tax Margin (%) | -140.12 |
| Quick Ratio | 2.49 |
| Current Ratio | 2.61 |
| ROA % (ttm) | -43.52 |
| ROE % (ttm) | -300.57 |
| ROIC % (ttm) | -82.68 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.97 |
RARE Number of Guru Trades
RARE Volume of Guru Trades
Gurus Latest Trades with NAS:RARE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RARE is held by these investors
Total 1
Ultragenyx Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:RARE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers